42 matches found.
RED, 10>1>3, Malignancy, immuno- suppression, Metoject®, Methotrexate pre-filled syringe, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14383
UNLICENSED SPECIAL, Malignant disease, rheumatic disease, Methotrexate liquid, Appendix 6, RED, Once weekly dosing, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14004
RED, 8>1>3, Methotrexate 10mg tablets, Malignancy, Non-proprietary, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14183
Golimumab, Simponi®, Methotrexate naive patients with Rheumatoid Arthritis (NICE TA224), Black traffic light, BLACK, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14322
Moderate rheumatoid arthritis after conventional DMARDs have failed [with methotrexate] - as per NICE TA715, 10>1>3, RED, CCG Commissioned [See - 'Rheumatoid Arthritis Recommended High-Cost Drugs Path...
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=23569
10.1.3 Drugs which suppress the rheumatic disease process
Last Modified: 14/01/2022
10.0 Musculoskeletal and joint diseases
Last Modified: 11/01/2022
13.0 Skin
Last Modified: 12/01/2022
8.0 Malignant Disease and Immunosuppression
Black Traffic Light Drugs (Not Recommended for Use)
NPSA Methotrexate Patient Briefing.pdf
Last Modified: 21/06/2016
Last Modified: 26/05/2016
